Antithrombotic therapy in patients with saphenous vein and internal mammary artery bypass grafts following percutaneous transluminal coronary angioplasty.
Stein
P D
PD
Dalen
J E
JE
Goldman
S
S
Schwartz
L
L
Turpie
A G
AG
Théroux
P
P
D015906:Angioplasty, Balloon, Coronary; D000925:Anticoagulants / Q000627:therapeutic use*; D001026:Coronary Artery Bypass; D003327:Coronary Disease / Q000628:therapy*; D006801:Humans; D007387:Internal Mammary-Coronary Artery Anastomosis; D010975:Platelet Aggregation Inhibitors / Q000627:therapeutic use*; D012008:Recurrence; D012501:Saphenous Vein / Q000637:transplantation; D013442:Sulfinpyrazone / Q000627:therapeutic use; D015912:Thrombolytic Therapy
D000925:Anticoagulants; D010975:Platelet Aggregation Inhibitors; D013442:Sulfinpyrazone